H. van Ormondt

4.0k citations

62 papers · 3.4k indexed · h-index 32

Genetics top 0.5%
- Virus-based gene therapy research 40
Molecular Biology top 5%
- Viral Infectious Diseases and Gene Expression in Insects 15
- RNA Interference and Gene Delivery 13
- CRISPR and Genetic Engineering 7
- Biochemical and Molecular Research 5
Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 10
Oncology top 5%
Animal Science and Zoology top 2%
Hematology
- Hemophilia Treatment and Research 6
Epidemiology
- Cytomegalovirus and herpesvirus research 6

Co-authors: A.J. van der Eb Rob C. Hoeben J. Maat Alex J. van der Eb Steve J. Cramer Frits J. Fallaux B.M.M. Dekker A. de Waard
Cited by: Genetics Molecular Biology Infectious Diseases
Journals: Gene (15 papers)Nucleic Acids Research (9 papers)Human Gene Therapy (3 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

H. van Ormondt

62 papers receiving 3.0k citations

Peers

Replace Yakov Gluzman with:

Yakov Gluzman United States

Göran Akusjärvi Sweden

D. R. Dubbs United States

C. Kédinger France

Mike Fried United Kingdom

Wolfram Ostertag Germany

Richard Mulligan United States

Christian C. Simonsen United States

Robert P. Ricciardi United States

Majid Mehtali France

H. van Ormondt relative to Yakov Gluzman United States Yakov Gluzman's profile →

Citations per field

00.5×2×3.3×

Yakov Gluzman · 1×

×1.5 2k/1k

GENET

×1.0 2k/2k

MB

×1.6 491/304

ID

×0.7 721/971

ONCOL

×1.7 213/124

ASZ

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by H. van Ormondt

Since Specialization

Citations

This map shows the geographic impact of H. van Ormondt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. van Ormondt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. van Ormondt more than expected).

Fields of papers citing papers by H. van Ormondt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. van Ormondt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. van Ormondt. The network helps show where H. van Ormondt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H. van Ormondt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. van Ormondt Line = papers co-authored together H. van Ormondt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ganciclovir nucleotides accumulate in mitochondria of rat liver cells expressing the herpes simplex virus thymidine kinase gene The Journal of Gene Medicine ·M.M. van der Eb,Sacha B. Geutskens,André B. P. Kuilenburg,Henk van Lenthe,Linxiu Dai,Peter J.K. Kuppen,H. van Ormondt,Cornelis J.�H. van de Velde,Ronald J. A. Wanders,Albert H. Gennip,Rob C. Hoeben	2003	13
2	Ammonium sulphate precipitation of recombinant adenovirus from culture medium: an easy method to increase the total virus yield Gene Therapy ·Frederik H.E. Schagen,Philippa Hedley-Takhar,Martijn J. W. E. Rabelink,H. van Ormondt,Alexandr Kovalenko,A.J. van der Eb,Rob C. Hoeben	2000	28
3	Specific tumor-cell killing with adenovirus vectors containing the apoptin gene Gene Therapy ·Alexandra M Pietersen,M.M. van der Eb,Philippa Hedley-Takhar,Diana J.M. van den Wollenberg,Martijn J. W. E. Rabelink,Peter J.K. Kuppen,Jan Hein van Dierendonck,H. van Ormondt,Céline Dekussche,Cornelis J.�H. van de Velde,A.J. van der Eb,Rob C. Hoeben,Mathieu H. M. Noteborn	1999	83
4	Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation Gene Therapy ·Frederik H.E. Schagen,Anne C.E. Moor,M.F.P. Rojer,Steve J. Cramer,H. van Ormondt,A.J. van der Eb,T.M.A.R. Dubbelman,Rob C. Hoeben	1999	44
5	New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent Adenoviruses Human Gene Therapy ·Frits J. Fallaux,A. Bout,Ietje van der Velde,Diana J.M. van den Wollenberg,Kathleen Hehir,秦克诚,Shavkat Imomov,Steve J. Cramer,H. van Ormondt,Alex J. van der Eb,Dinko Valerio,Rob C. Hoeben	1998	369
6	Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral Vectors Human Gene Therapy ·Frits J. Fallaux,Onno Kranenburg,Steve J. Cramer,Ada Houweling,H. van Ormondt,Rob C. Hoeben,Alex J. van der Eb	1996	457
7	Insertion of the human cytomegalovirus enhancer into a myeloproliferative sarcoma virus long terminal repeat creates a high-expression retroviral vector Gene ·Diana J.M. van den Wollenberg,Rob C. Hoeben,H. van Ormondt,Alex J. van der Eb	1994	6
8	Photodynamic inactivation of retroviruses by phthalocyanines: The effects of sulphonation, metal ligand and fluoride Journal of Photochemistry and Photobiology B Biology ·E. Ben‐Hur,Rob C. Hoeben,H. van Ormondt,T.M.A.R. Dubbelman,J. Van Steveninck	1992	46
9	Gene therapy for human inherited disorders: techniques and status Critical Reviews in Oncology/Hematology ·Rob C. Hoeben,Dinko Valerio,Alex J. van der Eb,H. van Ormondt	1992	18
10	Identical 3250-bp deletion between two AluI repeats in the ADA genes of unrelated ADA−SCID patients Genomics ·Th.M. Berkvens,H. van Ormondt,E.J.A. Gerritsen,P. Meera Khan,A.J. van der Eb	1990	32
11	Localization of human adenosine deaminase (ADA) gene sequences to the q12→q13.11 region of chromosome 20 by in situ hybridization Cytogenetic and Genome Research ·S.C. Jhanwar,Th.M. Berkvens,Cor Breukel,H. van Ormondt,A.J. van der Eb,P. Meera Khan	1989	12
12	Adenoslne deaminase gene expression is regulated posttranscriptionally in the nucleus Nucleic Acids Research ·Th.M. Berkvens,F. Schoute,H. van Ormondt,P. Meera Khan,A.J. van der Eb	1988	9
13	Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene Nucleic Acids Research ·Th.M. Berkvens,E.J.A. Gerritsen,Nodira K. Ruzmetova,Cor Breukel,Juul Wijnen,H. van Ormondt,Jaak M. Vossen,A.J. van der Eb,P. Meera Khan	1987	31
14	Naturally occurring BK virus variants (JL and Dik) with deletions in the putative early enhancer-promoter sequences Journal of Virology ·Jan ter Schegget,C. J. A. Sol,Elly Baan,J. van der Noordaa,H. van Ormondt	1985	27
15	Cloning of human adenosine deaminase cDNA and expression in mouse cells Gene ·Sean Colley,R. Scott McIvor,Steven R. Williams,M. G. C. Duyvesteyn,H. van Ormondt,Alex J. van der Eb,David W. Martin	1984	48
16	The nucleotide sequence of the transforming BglII-H fragment of adenovirus type 7 DNA Gene ·R. Dijkema,B.M.M. Dekker,H. van Ormondt	1980	20
17	The nucleotide sequence of the transforming early region E1 of adenovirus type 5 DNA Gene ·H. van Ormondt,J. Maat,Guzel Kazakbaeva	1980	67
18	Two sequence‐specific endonucleases from Anabaena oscillarioides FEBS Letters ·A. de Waard,Tarun Mehra,M. G. C. Duyvesteyn,H. van Ormondt	1979	16
19	The nucleotide sequence of the transforming HpaI-E fragment of adenovirus type 5 DNA Gene ·H. van Ormondt,J. Maat,A. de Waard,A.J. van der Eb	1978	139
20	The nucleotide sequence in the promoter region of the fene for an Escherichia coli tyrosine transfer ribonucleic acid. Journal of Biological Chemistry ·M. A. C. De-Lourenco,H. van Ormondt,H. Gobind Khorana	1975	24

About H. van Ormondt

H. van Ormondt is a scholar working on Genetics, Physiology, Molecular Biology, Infectious Diseases and Hematology, having authored 62 papers that have together received 3.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (40 papers), Viral Infectious Diseases and Gene Expression in Insects (15 papers), RNA Interference and Gene Delivery (13 papers), Viral gastroenteritis research and epidemiology (10 papers), CRISPR and Genetic Engineering (7 papers), Hemophilia Treatment and Research (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Biochemical and Molecular Research (5 papers). The work is most often cited by research in Genetics (2.1k citations), Molecular Biology (2.4k citations), Infectious Diseases (491 citations), Oncology (721 citations) and Animal Science and Zoology (213 citations). H. van Ormondt has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include A.J. van der Eb, Rob C. Hoeben, J. Maat, Alex J. van der Eb, Steve J. Cramer, Frits J. Fallaux, B.M.M. Dekker, A. de Waard, R. Dijkema and Onno Kranenburg. Their work appears in journals such as Gene, Nucleic Acids Research, Human Gene Therapy, FEBS Letters and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact